In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding.
Where this comes from
- Record sourced from PubMed, PMID 32805168.
- Also identified by DOI 10.7326/ACPJ202008180-021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Agnelli G, Becattini C, Meyer G, et al. <b>Apixaban for the treatment of venous thromboembolism associated with cancer.</b> N Engl J Med. 2020;382:1599-607. 32223112.
Medical subject headings
- Neoplasms
- Venous Thromboembolism